Alyssa, 1. The 510(k) that Arrayit is most likely currently working on is IMO the allergy test, not OvaDx. 2. OvaDx IP and its fate is, as far as we know, still in Avant's hands. And a few years back they changed the strategy to pursue a 510(k) to compete with CA125 test for monitoring instead of PMA for screening. There has been no announcements saying that the IP has reverted back to Arrayit. And Avant has been silent about Ovadx for a long time and is not even mentioning OvaDx on their website anymore.